Enveric Biosciences, Inc. (ENVB) › Net IncomeEnveric Biosciences, Inc. (ENVB) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$39.4K2011: -$33.4K2012: -$24.6K2013: -$1612014: -$33.6K2015: -$814.1K2016: -$2.78M2017: -$9.07M2018: -$16.90M2019: -$2.41M2020: -$6.86M2021: -$48.98M2022: -$18.47M2023: -$17.29M2024: -$9.57M2025: -$8.77M-$8.77M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$8.77M+8.4%2024-$9.57M+44.6%2023-$17.29M+6.4%2022-$18.47M+62.3%2021-$48.98M-613.5%2020-$6.86M-184.8%2019-$2.41M+85.7%2018-$16.90M-86.2%2017-$9.07M-226.4%2016-$2.78M-241.6%2015-$814.1K-2319.7%2014-$33.6K-20796.9%2013-$161+99.3%2012-$24.6K+26.2%2011-$33.4K+15.4%2010-$39.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share